Zwolle, 14 september 2020. Het Academisch Medisch Centrum (AZP) in Paramaribo, Suriname, heeft met succes onderzoek gedaan naar een efficiënte methode om COVID-19 patienten te behandelen met antilichamen-houdend plasma van …
The renowned European Institute for Innovation and Technology (EIT) has selected HemoClear to participate in the Bridgehead Europe programme. Best-in-class health care innovators In this prestigious program, the best-in-class health …
In times of crisis, it is good to have a partner like Oost NL. Where possible they show financial leniency and they bring proactive other support options to our attention.
An estimated 4 million women need a blood transfusion after giving birth annually. Now new research has found that their pregnancies put these women are at a higher risk of …
8 April 2020, Zwolle – In the fight against COVID-19, HemoClear’s current top priority is to help save lives, with COVID-19 convalescent plasma therapy. In spite of the incredibly global …
The persisting coronavirus epidemic is drying up Asian blood banks, further increasing the global blood shortage. Blood supplies fail the demand for emergency aid and other transfusion treatments. As a …
How Mohammed Kamruzzaman’s blood transfusion supports the preference for autologous blood for blood transfusion Autologous blood (patients’ own blood) is an invaluable source of transfusion blood. Especially when donor blood …
It was a pleasure to define with the experts of Task Force Healthcare and successful entrepreneur in international markets Willem van Prooijen, some valuable and practical improvements to HemoClear’s international …
A patient’s own salvaged red blood cells (autologous red blood cells) are functionally superior to donated red blood cells. This is the first out of seven reasons why autologous blood should be …
HemoClear and Pennine Healthcare team up to develop and manufacture a complete ready-to-use HemoClear accessories kit. The kit contains all material to recuperate red blood cells from patient shed blood, …
